Related Experiment Video
Updated: May 21, 2026
07:35
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
Published on: January 26, 2024
Hypoglycemia, diabetes, and cardiovascular disease
Janet K Snell-Bergeon1, R Paul Wadwa
1Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Center, Aurora, Colorado 80045, USA. Janet.snell-bergeon@ucdenver.edu
Diabetes Technology & Therapeutics
|June 2, 2012
Summary
Hypoglycemia, or low blood sugar, may increase cardiovascular disease (CVD) risk in people with diabetes. This review explores hypoglycemia
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Diseases
Background:
- Cardiovascular disease (CVD) is the primary cause of death in individuals with diabetes.
- While hyperglycemia is linked to microvascular complications, its role in CVD is less clear.
- Intensive glycemic control has increased hypoglycemia rates, raising concerns about cardiovascular risk.
Purpose of the Study:
- To review risk factors and prevalence of hypoglycemia in diabetes.
- To examine the association between hypoglycemia and CVD in adults with diabetes.
- To discuss potential mechanisms linking hypoglycemia to adverse cardiovascular outcomes.
Main Methods:
- Literature review of clinical trials and observational studies.
- Analysis of physiological effects of hypoglycemia on the cardiovascular system.
- Examination of epidemiological data on hypoglycemia and CVD incidence.
Main Results:
- Hypoglycemia is a growing concern with intensive glucose-lowering therapies.
- Evidence suggests acute and chronic hypoglycemia may adversely affect cardiovascular risk.
- Potential mechanisms include oxidative stress, cardiac arrhythmias, and ischemic brain damage.
Conclusions:
- Hypoglycemia represents a significant, under-recognized risk factor for CVD in diabetes.
- Further research is needed to elucidate the causal pathways between hypoglycemia and cardiovascular events.
- Clinical management strategies should consider the cardiovascular implications of hypoglycemia.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...